BHRB vs NBIX · P/E 8.4, rev $445.0M vs P/E 45, rev $1.77B
Burke & Herbert Financial Services Corp. Common Stock (BHRB) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Burke & Herbert Financial Services Corp. Common Stock (BHRB) is a banks - regional company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BHRB revenue for 2025-12-31 was $445.0M. Net income was $117.3M. Revenue was up 21.5% from 2024-12-31 to 2025-12-31. BHRB currently screens at market cap $1.30B and trailing P/E 8.4.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
BHRB currently screens at market cap $1.30B and trailing P/E 8.4. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the BHRB and NBIX stock pages for the full models.
Not investment advice.